Absence of BRAF and HRAS mutations in eruptive Spitz naevi

Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes

(2010) Irene Lurkin et al.   PLoS One

FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy

(2010) Lucie C. Kompier et al.   PLoS One

BRAF,NRASandHRASmutations in spitzoid tumours and their possible pathogenetic significance

(2009) P.D. Da Forno et al.   BRITISH JOURNAL OF DERMATOLOGY

Eruptive disseminated Spitz naevi: dermatoscopic features

(2009) I. Kilinc Karaarslan et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

OncogenicBRAFand the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations

(2009) Andrew Emley et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Alterations of the Cell-Cycle Inhibitors p27KIP1 and p16INK4a Are Frequent in Blastic Plasmacytoid Dendritic Cell Neoplasms

(2009) Thomas Wiesner et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY